8-K

================================================================================



                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                            ------------------------

                                    FORM 8-K

                                 Current Report

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

         Date of Report (Date of earliest event reported): March 5, 2002



                              EQUIDYNE CORPORATION
             (Exact name of registrant as specified in its charter)

            Delaware                       0-9922                 04-2608713
(State or other jurisdiction of   (Commission file number)     (I.R.S. Employer
 incorporation or organization)                              Identification No.)

11770 Bernardo Plaza Court, Suite 351,
       San Diego, California                                         92128
(Address of principal executive offices)                          (Zip code)

                                 (858) 451-7001
              (Registrant's telephone number, including area code)

                                 Not Applicable
          (Former name or former address, if changed since last report)



================================================================================






Item 5. Other Events.

     On March 5, 2002, Equidyne Corporation (the "Company") issued a press
release which announced the 2002 Annual Meeting of its Stockholders. A copy of
the press release is attached to this report as Exhibit 99.1.

Item 7. Financial Statements and Exhibits.

        Exhibit 99.1       Press Release dated March 5, 2002








                                   SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

Dated:  March 6, 2002

                                 EQUIDYNE CORPORATION
                                              (Registrant)


                                 By:    /s/ Marcus R. Rowan
                                        ----------------------------------------
                                        Name:  Marcus R. Rowan
                                        Title:    Chief Executive Officer

EX-99.1

For Immediate Release



San Diego, California, March 4, 2002: EQUIDYNE CORPORATION (AMEX: IJX) today
announced that its 2002 Annual Meeting of Stockholders will be held on May 28,
2002. Holders of record of the Company's common stock at the close of business
on April 4, 2002 will be entitled to notice of and to vote at the Annual
Meeting, and will be mailed a proxy statement. The deadline by which shareholder
proposals must have been submitted in order to be included in the proxy
statement for the Annual Meeting has passed. The date after which notice of a
shareholder proposal submitted outside the processes of Rule 14a-8 will be
considered untimely under the advance notice provisions of the Company's By-Laws
will be March 15, 2002.

About the Company:

Equidyne Corporation (www.equidyne.com), through Equidyne Systems, Inc., a
wholly-owned subsidiary based in San Diego, California, is focused on becoming
the worldwide leader in needle-free drug delivery systems for subcutaneous
injections. The INJEX(TM) needle-free injector is a compact, uncomplicated
device that delivers a virtually painless injection through the skin in a
fraction of a second, and eliminates needle stick and disposal problems. The
INJEX(TM) System is a comfortable, economical alternative to delivering
medications using conventional needle injections.

CONTACT:

        Jeffrey Weinress
        Equidyne Corporation
        (858) 451-7001

        Mark Wachs
        Mark Wachs and Associates
        (212) 832-2800